Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Translational Behavioral Medicine
Published in: Translational Behavioral Medicine 3/2011

01-09-2011

The Society of Behavioral Medicine (SBM) and public policy advocacy: a call to action

Authors: Paul Estabrooks, PhD, Sherry Pagoto, PhD, Jennifer Otten, PhD, RD, Lori Pbert, PhD, Amy Stone, Abby King, PhD, Kathy Goggin, PhD, Karen Emmons, PhD

Published in: Translational Behavioral Medicine | Issue 3/2011

Login to get access

ABSTRACT

In 2010, the Society of Behavioral Medicine heightened its priority to take an even more active role in influencing health-related public policy. Here we discuss the importance of behavioral medicine presence in public policy initiatives, review a brief history of SBM’s involvement in public policy, describe steps SBM is now taking to increase its involvement in health-related public policy, and finally, put forth a call to action for SBM members to increase their awareness of and become involved in public policy initiatives.
Literature
1.
Thun, M. J., & Jemal, A. (2006). How much of the decrease in cancer death rates in the United States is attributable to reductions in tobacco smoking? Tobacco Control, 15(5), 345–7.PubMedCrossRef
2.
Centers for Disease Control and Prevention. (2007). Cigarette smoking among adults–United States, 2006. Morbidity and Mortality Weekly Report, 56(44), 1157–1161.
3.
DPP Research Group. (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. The New England Journal of Medicine, 346(6), 393–403.CrossRef
4.
Tuomilehto, J., Lindstrom, J., Eriksson, J. G., Valle, T. T., Hamalainen, H., Ilanne-Parikka, P., et al. (2001). Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. The New England Journal of Medicine, 344(18), 1343–50.PubMedCrossRef
Metadata
Title
The Society of Behavioral Medicine (SBM) and public policy advocacy: a call to action
Authors
Paul Estabrooks, PhD
Sherry Pagoto, PhD
Jennifer Otten, PhD, RD
Lori Pbert, PhD
Amy Stone
Abby King, PhD
Kathy Goggin, PhD
Karen Emmons, PhD
Publication date
01-09-2011
Publisher
Springer-Verlag
Published in
Translational Behavioral Medicine / Issue 3/2011
Print ISSN: 1869-6716
Electronic ISSN: 1613-9860
DOI
https://doi.org/10.1007/s13142-011-0073-8

Other articles of this Issue 3/2011

Translational Behavioral Medicine 3/2011 Go to the issue

OriginalPaper

Delivering a lifestyle and weight loss intervention to individuals in real-world mental health settings: lessons and opportunities

OriginalPaper

A pilot study to expand the school breakfast program in one middle school

OriginalPaper

Long-term outcomes from a multiple-risk-factor diabetes trial for Latinas: ¡Viva Bien!

EditorialNotes

The current state of lifestyle intervention implementation research: where do we go next?

OriginalPaper

News from NIH: obesity and diabetes

OriginalPaper

Intervention costs and cost-effectiveness for a multiple-risk-factor diabetes self-management trial for Latinas: economic analysis of ¡Viva Bien!